跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FEDAC COMPOUND LINCTUS - PPB Drug Approval Details
Approvals
/
PPB
/
FEDAC COMPOUND LINCTUS
Approved
STANDARD
FEDAC COMPOUND LINCTUS
TEVA PHARMACEUTICAL HONG KONG O/B TEVA PHARMACEUTICAL HONG KONG LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
19e32ccb64f20bf0
Company
TEVA PHARMACEUTICAL HONG KONG O/B TEVA PHARMACEUTICAL HONG KONG LIMITED
Type
Standard
Approval Details
Approval Id
19e32ccb64f20bf0
Product Name
FEDAC COMPOUND LINCTUS
Drug Hk Name
FEDAC COMPOUND LINCTUS
Registration Code
HK-31777
Company Name
TEVA PHARMACEUTICAL HONG KONG O/B TEVA PHARMACEUTICAL HONG KONG LIMITED
Company Detail Path
/organization/teva-pharmaceutical-hong-kong-limited
Registration Category
Part 1 & Schedule 1 Poison & Part II & III Dangerous Drug
Sale Requirement
Pharmacy only Medicines
Registration Date
1989-05-04
Company Address
FLAT/RM 2303, 23/F, MIRA PLACE TOWER A, 132 NATHAN ROAD, TSIM SHA TSUI, KOWLOON
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
19e32ccb64f20bf0
Type
Standard
Back to PPB Approvals